• Latest Posts

Sanofi adds diabetes drug through Provention Bio $2.9B acquisition

Expert Advice 2 Mar 2023

5 steps to strategic partnerships for healthtech startups

GC Biopharma acquiring hemophilia rare disease pipeline

Crown Bioscience acquiring Indivumed’s service business and biobank

Five key trends shaping life sciences in 2023


Ensoma acquiring Twelve Bio

Blacksmith Medicines merging with Forge Therapeutics

Prenetics acquires ACT Genomics

Polyplus announces completion of acquisition of Xpress Biologics to expand plasmid DNA

New company Liminatus Pharma Inc to develop three cancer treatments